Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine as Adjuvant in Adductor Canal and Sciatic Nerve Block
ChiCTR-IPR-16008192Phase 4Recruiting
- Sponsor
- Xuanwu Hospital
- Start
- Mar 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of dexmedetomidine in Leg injuries (2 arms), sponsored by Xuanwu Hospital. Primary endpoints: Onset time of sensory block, Duration of sensory block and 2 more. Started Mar 2016; status: recruiting.
02
Drugs
dexmedetomidine
03
Conditions
Leg injuries
Beyond the preview
Go deeper on ChiCTR-IPR-16008192.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-16008192.